Evidence map›Paper›PMID 39397984›Full record

ArticleHeliyon2024

Research landscape of radiotherapy for nasopharyngeal carcinoma from 1959 to 2022: A bibliometric analysis.

Kaichun Huang, Xinqing Yang, Cuidai Zhang, Xuejia Liu, Yingji Hong, Qingxin Cai, Mei Li, Zhixiong Lin, Yizhou Yang

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaichun HuangDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Xinqing YangDepartment of Otolaryngology, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Cuidai ZhangDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Xuejia LiuShantou University Medical College, Shantou, Guangdong, China.
Yingji HongDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Qingxin CaiDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Mei LiDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zhixiong LinDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Yizhou YangDepartment of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Radiotherapy, as the main treatment method for nasopharyngeal carcinoma (NPC), has evolved over time, but there has been no bibliometric study on NPC radiotherapy to date. In our study, the scientific achievements of NPC radiotherapy around the world were evaluated by bibliometric analyses, and the previous research hotspots and future trends are described. Methods: Original articles related to NPC radiotherapy were obtained from the Web of Science Core Collection. To identify research hotspots and future trends, countries/regions, institutions, journals, references, authors, and keywords were evaluated and visualized by Excel, VOSviewer, and CiteSpace. Results: From 1959 to 2022, 7139 original articles were collected. The annual publications showed an increasing trend, especially after 2011. China had the most publications (n = 3719, 52.09 %). Sun Yat-sen University has the most publications and citations among institutions. Jun Ma is most productive and SR Baker has the highest co-cited centrality. Conclusion: NPC radiotherapy has attracted increasing attention, and precision and artificial intelligence may be the future trends in this field.

Indexed as

BibliometricNasopharyngeal carcinomaRadiotherapyWoSCC

Identifiers

PMID39397984
PMCPMC11470525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.